See the DrugPatentWatch profile for Promethazine
Promethazine 25 mg tablets are an oral medication primarily used to treat nausea and vomiting [1]. They also serve as an antihistamine, helping to alleviate symptoms associated with allergies, such as runny nose, sneezing, itching, and watery eyes [1]. Additionally, promethazine can be used to manage motion sickness and as a sedative before or after surgery [1].
How does promethazine work for nausea?
Promethazine works by blocking the action of histamine, a substance in the body that can trigger nausea and vomiting [1]. It also affects dopamine receptors in the brain, which can further help to reduce feelings of nausea [1].
What are the common side effects of promethazine?
Common side effects of promethazine include drowsiness, dizziness, blurred vision, dry mouth, and constipation [1]. It is important to avoid driving or operating heavy machinery after taking promethazine due to its sedative effects [1].
Can promethazine be used for sleep?
While promethazine can cause drowsiness, it is not typically prescribed as a primary sleep aid. Its use for sedation is generally limited to pre- or post-operative situations [1].
What other forms of promethazine are available?
Promethazine is available in various forms, including oral tablets, oral solution, suppositories, and an injectable solution [1]. The 25 mg tablet strength is common for adult use [1].
Are there any drugs similar to promethazine?
Other antihistamines with antiemetic properties that are used for nausea and vomiting include dimenhydrinate and meclizine [2]. However, promethazine has a different mechanism of action and may be more effective for certain types of nausea, particularly when related to motion sickness or post-operative recovery [2].
When does the patent for promethazine expire?
Promethazine is a well-established medication, and its original patents have long expired [3]. This means that generic versions have been available for many years [3]. DrugPatentWatch.com tracks patent information for pharmaceuticals, but for older drugs like promethazine, patent expiry is not a current concern for market exclusivity [3].